Background

In December 2019, Wuhan, China witnessed the outbreak of the novel coronavirus (SARS-CoV-2) that would soon become an international public health emergency and world pandemic.1 In the U.S., we are at a time where preparation for healthcare systems is critical. Given the rapidity with which the novel coronavirus (SARS-CoV-2) is spreading, we can expect an increased burden of cancer patients diagnosed with COVID-19 at oncology treatment clinics and a need to address this diagnosis. As of the date of this writing, the U.S.

Keywords

COVID-19, SARS-CoV-2, Treatment

DOWNLOAD PDF